Quality of life and survival analysis of patients undergoing transarterial chemoembolization for primary hepatic malignancies: a prospective cohort study
- 1 May 2012
- Vol. 14 (5), 341-350
- https://doi.org/10.1111/j.1477-2574.2012.00455.x
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- Prognostic factors for survival in patients with unresectable hepatocellular carcinoma undergoing chemoembolization with doxorubicin drug-eluting beads: a preliminary studyHPB, 2010
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal Of Cancer, 2009
- Decision making and quality of life in the treatment of cancer: a reviewSupportive Care in Cancer, 2008
- Multivariate Analysis of the Predictors of Survival for Patients with Hepatocellular Carcinoma Undergoing Transarterial Chemoembolization: Focusing on uperselective ChemoembolizationKorean Journal of Radiology, 2008
- Patterns of Cancer Incidence, Mortality, and Prevalence Across Five Continents: Defining Priorities to Reduce Cancer Disparities in Different Geographic Regions of the WorldJournal of Clinical Oncology, 2006
- Staging systems in hepatocellular carcinomaHPB, 2005
- Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survivalHepatology, 2003
- Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trialThe Lancet, 2002
- SF-36 Health Survey UpdateSpine, 2000
- Unresectable hepatocellular carcinoma in cirrhosisDigestive Diseases and Sciences, 1996